Printer Friendly

Baby rescue: cord blood saves infants with rare disease.

Few events shatter new parents' joy faster than learning that their baby has an incurable illness. One such condition is infantile Krabbe's disease, an inherited disorder of the nervous system. Because of an enzyme deficiency, the short lives of such infants are marked by irritability, feeding problems, seizures, blindness, and deafness. These babies usually die before age 2.

Doctors now report rescuing infants from Krabbe's disease with an infusion of umbilical cord blood from an unrelated donor.

Pediatrician Maria L. Escolar of the University of North Carolina at Chapel Hill and her colleagues there and at Duke University Medical Center in Durham, N.C., identified 11 babies before or soon after birth who had the enzyme deficiency but hadn't yet shown signs of Krabbe's disease. They also identified 14 other babies, ages 4 to 9 months, who lacked the enzyme but already showed symptoms of disease. The doctors gave all the children a drug that wipes out bone marrow and, a week or so later, transfused each baby with a dose of cord blood.

Follow-up ranging from a few months to nearly 6 years shows that all 11 participants who were treated as newborns are still alive, and 7 have passed their second birthdays. However, 8 of the 14 babies who received cord blood after showing symptoms of disease have died, the researchers report in the May 19 New England Journal of Medicine.

Moreover, the babies treated as newborns have shown normal vision and only two scored below normal on cognitive-development tests. Some exhibit motor-skills deficits such as problems walking.

In contrast, all the surviving children who received cord blood after showing signs of Krabbe's disease are severely disabled.

Because they lack the enzyme called galactocerebrosidase, children with Krabbe's disease fail to produce and maintain myelin, the fatty substance that insulates nerve fibers. Stem cells in transplanted bone marrow can grow into brain cells that produce galactocerebrosidase. However, locating a matching marrow donor is sometimes a lengthy process.

Finding a cord-blood donor is quicker. Cord-blood transplants don't need to come from as closely matched a donor as marrow cells do, says Escolar, and the donor doesn't require surgery.

Furthermore, cord-blood stem cells seem to establish themselves in the brain more reliably than marrow stem cells do, Escolar says.

"It's not often we get to see such an important piece of work," says geneticist Pablo Rubinstein of the New York Blood Center. Escolar's findings suggest that doctors should screen all newborns for Krabbe's disease, Rubinstein says. "We shouldn't be waiting until we have cause" to look for it, he adds.
COPYRIGHT 2005 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 
Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:This Week
Author:Seppa, N.
Publication:Science News
Geographic Code:1U5NC
Date:May 21, 2005
Words:429
Previous Article:Perfect match: embryonic stem cells carry patients' DNA.
Next Article:New mammals: coincidence, shopping yield two species.
Topics:


Related Articles
Umbilical clamping affects anemia risk.
'MIRACLE' BRINGS NEW LIFE UMBILICAL-CORD BLOOD GIVES BOYS IMMUNITY.
CELL TRANSPLANT REVIVES HOPE IN ILL BOY, FAMILY.
UMBILICAL CORD MIRACLE?
BABY GETS FIGHTING CHANCE\Transplant prognosis good.
UMBILICAL CORD BLOOD HAILED AS IMMUNE SYSTEM RESTORATIVE.
WOMEN : STUDY LINKS OBESITY OF MOMS TO BIRTH DEFECTS.
LIFEBLOOD BANKING UMBILICAL CORD STEM CELLS FOR TREATMENT OF DISEASES SEEMS LIKE GOOD INSURANCE - BUT DOES THE POLICY REALLY PAY OFF?
Infusions help babies with Hurler's syndrome.
Infant disease testing still a gamble from state to state.

Terms of use | Privacy policy | Copyright © 2018 Farlex, Inc. | Feedback | For webmasters